{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:08:12Z","timestamp":1768630092610,"version":"3.49.0"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Florida Department of Health and the Bankhead-Coley Cancer Research Program","award":["1BG-08"],"award-info":[{"award-number":["1BG-08"]}]},{"name":"JSPS Grant-in-Aid for Young Scientists (B)","award":["15K19893"],"award-info":[{"award-number":["15K19893"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0161618","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T18:17:44Z","timestamp":1472149064000},"page":"e0161618","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment"],"prefix":"10.1371","volume":"11","author":[{"given":"Ryuichi","family":"Hotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Tryphonopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akin","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Selvaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camillo","family":"Ricordi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Vianna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ohdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Waldmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas G.","family":"Tzakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1399-0039.1990.tb01767.x","article-title":"The CAMPATH-1 antigen (CDw52)","volume":"35","author":"G Hale","year":"1990","journal-title":"Tissue Antigens"},{"issue":"2\u20133","key":"ref2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.trim.2011.07.002","article-title":"Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation","volume":"25","author":"J Sageshima","year":"2011","journal-title":"Transpl Immunol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1399-3046.2011.01615.x","article-title":"Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection","volume":"16","author":"K Upadhyay","year":"2012","journal-title":"Pediatr Transplant"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells","volume":"47","author":"G Trinchieri","year":"1989","journal-title":"Adv Immunol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0952-7915(03)00039-6","article-title":"Natural killer cell receptor signaling","volume":"15","author":"LL Lanier","year":"2003","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.4049\/jimmunol.156.7.2436","article-title":"LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells","volume":"156","author":"M Takahashi","year":"1996","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-0528.2002.017404.x","article-title":"The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses","volume":"174","author":"S Seki","year":"2000","journal-title":"Immunol Rev"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hep.20204","article-title":"Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice","volume":"39","author":"M Ochi","year":"2004","journal-title":"Hepatology"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1097\/01.tp.0000250935.41034.2d","article-title":"Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy","volume":"82","author":"M Ohira","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.21035","article-title":"Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans","volume":"43","author":"K Ishiyama","year":"2006","journal-title":"Hepatology"},{"key":"ref11","article-title":"Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma","author":"M Ohira","year":"2012","journal-title":"Cell Transplant"},{"issue":"11","key":"ref12","first-page":"3226","article-title":"Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice","volume":"119","author":"M Ohira","year":"2009","journal-title":"J Clin Invest"},{"issue":"7229","key":"ref13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"JC Sun","year":"2009","journal-title":"Nature"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"e39416","DOI":"10.1371\/journal.pone.0039416","article-title":"Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis","volume":"7","author":"SP Rao","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nri3065","article-title":"Organ-specific features of natural killer cells","volume":"11","author":"FD Shi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-065X.2006.00435.x","article-title":"Cellular and molecular mechanisms of liver tolerance","volume":"213","author":"IN Crispe","year":"2006","journal-title":"Immunol Rev"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2567.2009.03115.x","article-title":"Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model","volume":"128","author":"Y Hu","year":"2009","journal-title":"Immunology"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood.V100.5.1715.h81702001715_1715_1720","article-title":"Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab","volume":"100","author":"AG Buggins","year":"2002","journal-title":"Blood"},{"issue":"3\u20134","key":"ref19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/10428199009053522","article-title":"Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated Campath-1 Monoclonal-Antibodies","volume":"2","author":"MJS Dyer","year":"1990","journal-title":"Leukemia Lymphoma"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0161618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T02:03:59Z","timestamp":1718762639000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0161618"}},"subtitle":[],"editor":[{"given":"R. Keith","family":"Reeves","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":19,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0161618","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]}}}